What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?

Expert Review of Anti-Infective Therapy - United Kingdom
doi 10.1080/14787210.2016.1233060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Pharmacodynamic Modeling of Β-Lactam / Β-Lactamase Inhibitor Checkerboard Data: Illustration With Aztreonam-Avibactam

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Using Β-Lactam/Β-Lactamase Inhibitors for Infections Due to Extended-Spectrum Β-Lactamase-Producing Enterobacteriaceae to Slow the Emergence of Carbapenem-Resistant Enterobacteriaceae

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2017English

Author Correction: Interplay Between Β-Lactamases and New Β-Lactamase Inhibitors

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

Reclaiming the Efficacy of -Lactam- -Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia Coli to Ceftazidime

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

The Postantibiotic Effect and Post-Β-Lactamase-Inhibitor Effect of Ceftazidime, Ceftaroline and Aztreonam in Combination With Avibactam Against Target Gram-Negative Bacteria

Letters in Applied Microbiology
Applied MicrobiologyBiotechnology
2016English

Fluoroquinolones Versus Β-Lactam/Β-Lactamase Inhibitors in Outpatients With Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Theaflavin‐3,3´‐digallate Increases the Antibacterial Activity of Β‐lactam Antibiotics by Inhibiting Metallo‐β‐lactamase Activity

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy